Health · NZ ·

Pembrolizumab Plus Radiation Fails to Improve Recurrence-Free Survival in Early-Stage High-Intermediate–Risk d

OncLive · Health

Published

Pembrolizumab Plus Radiation Fails to Improve Recurrence-Free Survival in Early-Stage High-Intermediate–Risk d

Read it at the source

OncLive↗

We link out rather than republish. The reporting belongs to the publications above; the summary and the search data on this page are ours.

More trending now